February 26, 2018 / 12:10 PM / 3 months ago

BRIEF-Eagle Pharmaceuticals Reports Q4 EPS Of $0.58

Feb 26 (Reuters) - Eagle Pharmaceuticals Inc:

* EAGLE PHARMACEUTICALS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

* Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.00

* Q4 REVENUE $46.8 MILLION VERSUS $81.1 MILLION

* Q4 EARNINGS PER SHARE VIEW $1.00, REVENUE VIEW $52.9 MILLION — THOMSON REUTERS I/B/E/S

* 2018 RESEARCH AND DEVELOPMENT EXPENSE IS EXPECTED TO BE IN RANGE OF $46 MILLION TO $50 MILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below